Displaying 1-8 of 8 result(s).
| Board Name | Posts By slmiley | Post Created |
|---|---|---|
| AMBS Amarantus Bioscience Holdings | Another R/S? Unreal. How many rever  (2) | 04/21/2016 4:57:30 PM |
| AMBS Amarantus Bioscience Holdings | Damn, I was really hoping they woul (1) | 03/11/2016 1:40:23 PM |
| AMBS Amarantus Bioscience Holdings | No one was able to get in. They cha | 01/08/2016 11:45:01 AM |
| AMBS Amarantus Bioscience Holdings | Good news seeing Gemini owning 10% | 12/29/2015 8:15:01 PM |
| AMBS Amarantus Bioscience Holdings | Yes, they are. They had plenty of s | 12/21/2015 2:51:22 PM |
| AMBS Amarantus Bioscience Holdings | $AMBS Investors, don't fall for CAN | 12/21/2015 2:26:13 PM |
| AMBS Amarantus Bioscience Holdings | Form 4 Insider AMBS Buy filed today | 12/04/2015 9:36:22 AM |
| AMBS Amarantus Bioscience Holdings | Big LymPro News after hours today!! | 01/14/2015 2:41:46 PM |
Recent Articles
- Thanksgiving 2024 Travel: A Surge in Travelers Amid Challenges
- Exploring Legal Paths for Chipotle Investors Facing Losses
- Join the $JENNER Class Action and Protect Your Investment
- Invesque Inc. Approves Major Financial Enhancements for Shareholders
- Eli Lilly & Company Experiences Significant Stock Surge Today
- Investigation Launched into ASP Isotopes Inc. and Its Practices
- JOYY Inc. Updates Their 2024 Financial Performance Insights
- China's Economic Forecast for 2025: Challenges and Opportunities
- Inflation Data: Key Focus for US Stock Market Stability Ahead
- ION Mining Launches Cutting-Edge Mobile App for Enthusiasts
- New Australian Bill Seeks to Protect Children from Social Media
- Investors Standing Against PACS Group's Alleged Misconduct
- Important SEC Class Action Deadline for PACS Group Investors
- Investors Eye Legal Actions as Xiao-I Faces Serious Allegations
- Final Approval of Settlement Marks a New Era for Realtors
- United Airlines Faces Challenges Due to Air Traffic Control Shortages
- South Korea's Pension Fund Adjusts Dollar Holdings Amid Market Changes
- NorthWest Copper Welcomes Paul Olmsted as New CEO
- Investigation Launched as Acadia Healthcare Faces Claims
- Investigation Launched for Match Group Investors Amid Significant Losses
- Navigating Market Opportunities: Strategies for Investors in 2024
- Hydreight Technologies Achieves Major Revenue Growth in Q3
- Legal Investigations Alert: Shareholder Rights and Actions
- NOVONIX Set to Shine at December Investor Engagements
- Montfort Capital Reports Q3 Financials and Divestment Plan
- Understanding Distribution Sources of Cohen & Steers Fund (RNP)
- Exploring the Innovative Landscape of Cannabis with High Science
- Understanding Cohen & Steers Total Return Realty Fund Distributions
- Investment Insights from Cohen & Steers Opportunity Fund
- Xerox Holdings Corporation: Investigating Investor Claims and Losses
- Investigation Notice: Humacyte Investors Should Act Now
- Fusion Fuel's Strategic Acquisition and Leadership Transition
- Rivalry Corp. Announces Successful Non-Brokered Placement Raise
- Cohen & Steers Infrastructure Fund Updates Distribution Insights
- Growth Surge in Voice Evacuation Systems: A 1.1 Billion Leap
- FIBRA Prologis Completes Tender Offer for Terrafina CBFIs
- Understanding Distribution Sources for Cohen & Steers Realty Fund
- Marpai Secures New Clients and Prepares for 2025 Growth
- Lumina Gold's New Exploitation Contract Marks a Milestone
- Goldman Sachs Shares Hedging Strategies for 2025 Market Risks
- WattEV Advances EV Charging with New Rapid-Charging Standards
- DIRTT Environmental Solutions Welcomes Holly Hess Groos
- Mondee Faces Nasdaq Compliance Challenge Amid Leadership Changes
- Teamsters Union Grows as FreshPoint Drivers Take a Stand
- Challenges of Cannabis Legalization: Insights from Berlin's Justice Senator
- TerrAscend Elevates Lynn Gefen to Chief People Officer Role
- Maximus Inc Faces Uncertainty After Contract Cancellation
- Kentucky's New Medical Cannabis Licenses Create Excitement
- Franklin Templeton Updates Investors on ETF Liquidation Plans
- Peoples Financial Corporation Announces Cash and Special Dividends